AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMRICOR MEDICAL SYSTEMS-CDI

1.460

+0.0201.39%

Volume:106.73K

Turnover:154.74K

Market Cap:468.58M

PE:-7.42

High:1.465

Open:1.440

Low:1.410

Close:1.440

52wk High:1.855

52wk Low:0.930

Shares:320.95M

Float Shares:275.05M

Volume Ratio:0.46

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.197

EPS(LYR):-0.201

ROE:-432.29%

ROA:-38.22%

PB:13.41

PE(LYR):-7.27

Loading ...

Overview Company News Filings

BRIEF-Imricor Medical Systems Says IRB Approved UVA Health's Enrolment In Visabl-Afl Clinical Trial

Imricor Enrolls US University's Academic Health System as Site for Atrial Flutter Treatment Trial

MT Newswires Live

Imricor Medical Systems - Institutional Review Board Approved Uva Health's Enrolment in Co's Visabl-Afl Clinical Trial

THOMSON REUTERS

Is Imricor Medical Systems (ASX:IMR) Using Debt In A Risky Way?

Simply Wall St.

Imricor Medical Systems Inc-Imricor Appoints Aldo Denti to Board of Directors

THOMSON REUTERS

ASX Midday Sector Update: Healthcare Stocks Stay in Green, Utilities Sector Leads Selloff

MT Newswires Live

BUZZ-Australia's Imricor Medical Systems jumps on clinical trial progress

Imricor Says First Ischemic Ventricular Tachycardia Ablation Completed Under MRI Guidance; Shares Jump 11%

MT Newswires Live

Imricor Medical Systems Inc-Imricor Q3 Cy25 Quarterly Activities Report and Appendix 4C

THOMSON REUTERS

Imricor Medical Completes First In Vivo Pulsed Field Ablation in Ventricle Under MRI Guidance

MT Newswires Live

An Insider At Imricor Medical Systems Lowered Their Holding Recently

Simply Wall St.

Imricor Medical Systems Advances US FDA Review Process With Completion of Human Factors Study

MT Newswires Live

Imricor Medical Systems Inc - Succesfully Completes Human Factors Study for All Devices in FDA Approval Pathway

THOMSON REUTERS

BRIEF-Imricor Medical Systems Submits FDA 510(K) Approval For Vision-Mr Diagnostic

Imricor Medical Systems Submits Diagnostic Catheter for US FDA Premarket Notification Pathway Approval

MT Newswires Live

Imricor Medical Systems Inc - Submission of FDA 510(K) Approval for Vision-Mr Diagnostic

THOMSON REUTERS

BRIEF-Imricor Medical Systems Posts HY Loss After Tax $13.1 Million

Imricor Medical Systems Inc - Hy Loss After Tax $13.1 Mln

THOMSON REUTERS

Imricor Expects Steady US-FDA Approvals Through Year-End; Shares Fall 3%

MT Newswires Live

Imricor Medical Systems Inc-Imricor Q2 Cy25 Quarterly Activities Report and Appendix 4C

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IMR.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","market":"AU","secType":"STK","nameCN":"IMRICOR MEDICAL SYSTEMS-CDI","latestPrice":1.46,"timestamp":1765948320000,"preClose":1.44,"halted":0,"volume":106731,"delay":0,"nameEN":"IMRICOR MEDICAL SYSTEMS-CDI","floatShares":275046474,"shares":320947028,"eps":-0.19670400891610562,"marketStatus":"Not Yet Opened","change":0.02,"latestTime":"12-17 16:12:00 AEDT","open":1.44,"high":1.465,"low":1.41,"amount":154744,"amplitude":0.038194,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.19670400891610562,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1766012400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":1.44,"openAndCloseTimeList":[[1765926000000,1765947600000]],"volumeRatio":0.4599328270801498,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","floatShares":275046474,"roa":"-38.22%","roe":"-432.29%","lyrEps":-0.200729,"volumeRatio":0.4599328270801498,"shares":320947028,"dividePrice":0,"high":1.465,"amplitude":0.038194,"preClose":1.44,"low":1.41,"week52Low":0.93,"pbRate":"13.41","psRate":"413.39","week52High":1.855,"institutionHeld":0,"latestPrice":1.46,"eps":-0.19670400891610562,"divideRate":0,"volume":106731,"delay":0,"ttmEps":-0.19670400891610562,"open":1.44,"prevYearClose":1.36,"prevWeekClose":1.42,"prevMonthClose":1.5,"prevQuarterClose":1.405,"fiveDayClose":1.43,"twentyDayClose":1.35,"sixtyDayClose":1.42,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMR.AU\",params:#limit:5,,,undefined,":[{"date":"2025-08-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756166400000,"name":null,"time":"","dateTimestamp":1756130400000,"actualEps":null},{"date":"2025-02-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-28","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724803200000,"name":null,"time":"","dateTimestamp":1724767200000,"actualEps":null},{"date":"2024-04-30","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1714435200000,"name":null,"time":"","dateTimestamp":1714399200000,"actualEps":null},{"date":"2024-02-29","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709161200000,"name":null,"time":"","dateTimestamp":1709125200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMR.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2591693383","title":"BRIEF-Imricor Medical Systems Says IRB Approved UVA Health's Enrolment In Visabl-Afl Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2591693383","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591693383?lang=en_us&edition=fundamental","pubTime":"2025-12-15 09:04","pubTimestamp":1765760690,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Says IRB Approved UVA Health's Enrolment In Visabl-Afl Clinical TrialDec 15 (Reuters) - Imricor Medical Systems Inc IMR.AX:INSTITUTIONAL REVIEW BOARD APPROVED UVA HEALTH'","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nFWN3XI0RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","BK7503","BK7508","IMR.AU"],"gpt_icon":0},{"id":"2591066032","title":"Imricor Enrolls US University's Academic Health System as Site for Atrial Flutter Treatment Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2591066032","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591066032?lang=en_us&edition=fundamental","pubTime":"2025-12-15 07:34","pubTimestamp":1765755243,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  enrolled UVA Health to serve as the second US site for the company's Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter  clinical trial, according to a Monday filing with the Australian bourse.The company expects the final approval of the site's research contract in the coming days, site installation and clinical training in January 2026, and to start procedures in February 2026, the filing said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK7508","IMR.AU","BK7503"],"gpt_icon":0},{"id":"2591629976","title":"Imricor Medical Systems  -  Institutional Review Board Approved Uva Health's Enrolment in Co's Visabl-Afl Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2591629976","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591629976?lang=en_us&edition=fundamental","pubTime":"2025-12-15 05:25","pubTimestamp":1765747543,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251214:nFWN3XI0RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IMR.AU","BK7508","BK7503"],"gpt_icon":0},{"id":"2586299905","title":"Is Imricor Medical Systems (ASX:IMR) Using Debt In A Risky Way?","url":"https://stock-news.laohu8.com/highlight/detail?id=2586299905","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586299905?lang=en_us&edition=fundamental","pubTime":"2025-11-27 07:20","pubTimestamp":1764199234,"startTime":"0","endTime":"0","summary":"Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-imr/imricor-medical-systems-shares/news/is-imricor-medical-systems-asximr-using-debt-in-a-risky-way","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-imr/imricor-medical-systems-shares/news/is-imricor-medical-systems-asximr-using-debt-in-a-risky-way","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","IMR.AU","BK7503","EBIT","BK7007"],"gpt_icon":0},{"id":"2582816521","title":"Imricor Medical Systems Inc-Imricor Appoints Aldo Denti to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2582816521","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582816521?lang=en_us&edition=fundamental","pubTime":"2025-11-10 05:54","pubTimestamp":1762725276,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251109:nTUEKLLKV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IMR.AU","BK7503","BK7508"],"gpt_icon":0},{"id":"2580279060","title":"ASX Midday Sector Update: Healthcare Stocks Stay in Green, Utilities Sector Leads Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2580279060","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580279060?lang=en_us&edition=fundamental","pubTime":"2025-11-04 10:29","pubTimestamp":1762223380,"startTime":"0","endTime":"0","summary":"The healthcare sector inched up just 0.1% at midday Tuesday, with all other sectors on the Australian bourse trading in the red. The Reserve Bank of Australia is expected to maintain its monetary policy at its meeting today.Imricor Medical Systems , whose shares jumped over 11%, said the first in-human ischemic ventricular tachycardia ablation ever performed under real-time magnetic resonance imaging  guidance was completed in an interventional cardiac magnetic resonance imaging laboratory. The procedure was performed at the Amsterdam University Medical Centre.On the flip side, the utilities sector led the selloff, falling more than 2%.Energy World  appointed Joseph Meyer as chief financial officer, effective Nov. 1.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK4137","BK4585","BK7032","LABU","HCSG","BK4581","BK7007","BK4588","XLV","IMR.AU","XJO.AU","XBI","XAO.AU","XKO.AU","EWC.AU","LU0029874061.USD","BK7503","LU0128526141.USD"],"gpt_icon":0},{"id":"2580384276","title":"BUZZ-Australia's Imricor Medical Systems jumps on clinical trial progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2580384276","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580384276?lang=en_us&edition=fundamental","pubTime":"2025-11-04 09:40","pubTimestamp":1762220437,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Imricor Medical Systems jumps on clinical trial progress** Imricor Medical Systems IMR.AX jumps as much as 15% to A$1.57; marks biggest intraday pct jump since September 9** Stock hits highest since October 7; among top gainers on All Ordinaries index .AORD** Medical devices maker announces successful completion of first ischemic ventricular tachycardia ablation ever performed under real-time MRI guidance in an iCMR lab** Procedure meant to rectify hearth rythm disorder** YTD, IMR gains 11.8%  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nL6N3WG03J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMR.AU","BK7503","BK7508","BK7007"],"gpt_icon":0},{"id":"2580709273","title":"Imricor Says First Ischemic Ventricular Tachycardia Ablation Completed Under MRI Guidance; Shares Jump 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580709273","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580709273?lang=en_us&edition=fundamental","pubTime":"2025-11-04 09:15","pubTimestamp":1762218943,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  completed the first in-human ischemic ventricular tachycardia ablation ever performed under real-time magnetic resonance imaging  guidance in an interventional cardiac magnetic resonance imaging laboratory, according to a Tuesday Australian bourse filing.The procedure was performed at the Amsterdam University Medical Centre, the filing said. A first-in-human MRI-guided transseptal crossing was conducted using Imricor's NavTrac-MR transseptal kit and needle, while a first left ventricular mapping and ablation was performed with Imricor's Vision-MR ablation catheter 2.0.The medical device company's shares jumped over 11% in recent trading on Tuesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK7503","IMR.AU","BK7508"],"gpt_icon":0},{"id":"2577858333","title":"Imricor Medical Systems Inc-Imricor Q3 Cy25 Quarterly Activities Report and Appendix 4C","url":"https://stock-news.laohu8.com/highlight/detail?id=2577858333","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577858333?lang=en_us&edition=fundamental","pubTime":"2025-10-22 06:42","pubTimestamp":1761086573,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nTUE79W5TG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMR.AU","BK7007","BK7508","BK7503"],"gpt_icon":0},{"id":"2576886288","title":"Imricor Medical Completes First In Vivo Pulsed Field Ablation in Ventricle Under MRI Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2576886288","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576886288?lang=en_us&edition=fundamental","pubTime":"2025-10-20 10:57","pubTimestamp":1760929034,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said it completed the first-ever pre-clinical animal study in vivo pulsed field ablation in the ventricle under real-time magnetic resonance imaging  guidance in an interventional cardiac magnetic resonance imaging laboratory, according to a Monday Australian bourse filing.The procedure was performed using the firm's second-generation Vision-MR ablation catheter at its iCMR Design Center, validating its technology for integrating pulsed field ablation energy with real-time MRI visualization.The firm's shares fell 1% in recent trading on Monday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7503","MRI.AU","BK7007","IMR.AU","BK7508","BK7057"],"gpt_icon":0},{"id":"2572630005","title":"An Insider At Imricor Medical Systems Lowered Their Holding Recently","url":"https://stock-news.laohu8.com/highlight/detail?id=2572630005","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572630005?lang=en_us&edition=fundamental","pubTime":"2025-10-04 04:27","pubTimestamp":1759523268,"startTime":"0","endTime":"0","summary":"Viewing insider transactions for Imricor Medical Systems, Inc.'s ( ASX:IMR ) over the last year, we see that insiders...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-imr/imricor-medical-systems-shares/news/an-insider-at-imricor-medical-systems-lowered-their-holding","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-imr/imricor-medical-systems-shares/news/an-insider-at-imricor-medical-systems-lowered-their-holding","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IMR.AU","BK7007","BK7508","BK7503"],"gpt_icon":0},{"id":"2568058445","title":"Imricor Medical Systems Advances US FDA Review Process With Completion of Human Factors Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2568058445","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568058445?lang=en_us&edition=fundamental","pubTime":"2025-09-18 08:27","pubTimestamp":1758155234,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said the human factors study covering all of its devices currently under review by the US Food and Drug Administration has been completed, according to a Thursday Australian bourse filing.The study is a critical step in the US FDA approval process, ensuring that each device can be used safely and effectively by clinicians in real-world settings, the filing added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU","BK7007","BK7508","BK7503"],"gpt_icon":0},{"id":"2568444854","title":"Imricor Medical Systems Inc - Succesfully Completes Human Factors Study for All Devices in FDA Approval Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2568444854","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568444854?lang=en_us&edition=fundamental","pubTime":"2025-09-18 06:54","pubTimestamp":1758149644,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nFWN3V410C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","BK7503","IMR.AU","BK7508"],"gpt_icon":0},{"id":"2564869251","title":"BRIEF-Imricor Medical Systems Submits FDA 510(K) Approval For Vision-Mr Diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2564869251","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564869251?lang=en_us&edition=fundamental","pubTime":"2025-09-01 09:34","pubTimestamp":1756690482,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Submits FDA 510(K) Approval For Vision-Mr DiagnosticSept 1 (Reuters) - Imricor Medical Systems Inc IMR.AX:SUBMISSION OF FDA 510(K) APPROVAL FOR VISION-MR DIAGNOSTICFurther company coverage: IMR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250901:nFWN3UL1KR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMR.AU","BK7007","BK7503","BK7508"],"gpt_icon":0},{"id":"2564686949","title":"Imricor Medical Systems Submits Diagnostic Catheter for US FDA Premarket Notification Pathway Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2564686949","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564686949?lang=en_us&edition=fundamental","pubTime":"2025-09-01 09:32","pubTimestamp":1756690344,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  submitted its Vision-MR diagnostic catheter for approval under the US Food and Drug Administration's  510 premarket notification pathway, according to a Monday Australian bourse filing.The diagnostic catheter is designed to be used under real-time magnetic resonance imaging  guidance and is a key component of Imricor's full platform of MRI-compatible electrophysiology devices, per the filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7503","IMR.AU","BK7057","BK7007","MRI.AU","BK7508"],"gpt_icon":0},{"id":"2564868956","title":"Imricor Medical Systems Inc - Submission of FDA 510(K) Approval for Vision-Mr Diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2564868956","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564868956?lang=en_us&edition=fundamental","pubTime":"2025-09-01 07:19","pubTimestamp":1756682377,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250831:nFWN3UL1KR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","BK7503","BK7508","IMR.AU"],"gpt_icon":0},{"id":"2562721992","title":"BRIEF-Imricor Medical Systems Posts HY Loss After Tax $13.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2562721992","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562721992?lang=en_us&edition=fundamental","pubTime":"2025-08-26 09:11","pubTimestamp":1756170706,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Posts HY Loss After Tax $13.1 MillionAug 26 (Reuters) - Imricor Medical Systems Inc IMR.AX:HY LOSS AFTER TAX $13.1 MILLIONFurther company coverage: IMR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nFWN3UH0SI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMR.AU","BK7007","BK7508","BK7503"],"gpt_icon":0},{"id":"2562273794","title":"Imricor Medical Systems Inc - Hy Loss After Tax $13.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2562273794","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562273794?lang=en_us&edition=fundamental","pubTime":"2025-08-26 06:06","pubTimestamp":1756159612,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nFWN3UH0SI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","IMR.AU","BK7508","BK7007"],"gpt_icon":0},{"id":"2554723369","title":"Imricor Expects Steady US-FDA Approvals Through Year-End; Shares Fall 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554723369","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554723369?lang=en_us&edition=fundamental","pubTime":"2025-07-28 13:59","pubTimestamp":1753682373,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said it expects a \"steady string\" of US Food and Drug 510 product submissions and approvals through the remainder of the year, according to a Monday filing with the Australian bourse.During the June quarter, the company's cash balance fell to $50.3 million from $53.9 million in the March quarter.Shares of the company fell past 3% in recent Monday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","IMR.AU","BK7508","BK7503"],"gpt_icon":0},{"id":"2554746849","title":"Imricor Medical Systems Inc-Imricor Q2 Cy25 Quarterly Activities Report and Appendix 4C","url":"https://stock-news.laohu8.com/highlight/detail?id=2554746849","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554746849?lang=en_us&edition=fundamental","pubTime":"2025-07-28 06:24","pubTimestamp":1753655044,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250727:nTUE9N9XFW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMR.AU","BK7508","BK7503","BK7007"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}]}}